(3)Commission Directive 2008/66/ECnote included fenoxaprop-P in Annex I to Directive 91/414/EEC as an active substance until 31 December 2018 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of fenoxaprop-P was extended nine times, most recently by Implementing Regulation (EU) 2025/787 until 30 November 2026.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.